title: Nitrate-enhanced thallium 201 single-photon emission computed tomography imaging in hibernating myocardium.
abstract: OBJECTIVE
  This study tested the usefulness of nitrate-enhanced thallium 201 imaging for detecting myocardial viability.
  
  
  BACKGROUND
  Previous work suggests that nitrates enhance the ability of (201)Tl imaging to detect viable myocardium.
  
  
  METHODS
  Eighteen patients with coronary artery disease underwent (201)Tl imaging at rest, after 4 hours of redistribution, and during intravenous nitroglycerine infusion (mean dose = 5.96 +/- 5.37 microgram/kg/min). Twelve patients had their echocardiograms repeated after revascularization. Perfusion and wall motion were scored from 0 to 2 (absent to normal).
  
  
  RESULTS
  All the regions identified as viable by the rest/redistribution pair of scans were identified as viable by the rest/nitroglycerine pair of scans. Ninety-one percent of these regions were identified as viable by the single nitroglycerine scan alone. In patients who underwent revascularization, the total (201)Tl perfusion score improved from 193 to 214 after revascularization (P =.009). Wall motion score improved from 151 to 168 after revascularization (P =.09). Both the rest/nitroglycerine and rest/redistribution studies correctly predicted 14 (88%) of 16 regions that improved after revascularization. Most importantly, the rest/nitroglycerine and rest/redistribution studies were able to predict postrevascularization myocardial viability (absence of akinesis or dyskinesis after revascularization), with a sensitivity of 95% and 92%, respectively, and a predictive accuracy of 84.4%.
  
  
  CONCLUSIONS
  Nitroglycerine infusion during (201)Tl imaging is a useful technique for detecting underperfused, viable myocardium, requires less time to perform than rest/redistribution imaging, and may allow detection of viable myocardium with a single (201)Tl single-photon emission computed tomographic study.
authors.affiliation: Saint John's Cardiovascular Research Center, Department of Medicine, Torrance, CA 90509, USA. oudiz@harbor2.humc.edu
authors.forename: R J
authors.initials: RJ
authors.lastname: Oudiz
authors.forename: D E
authors.initials: DE
authors.lastname: Smith
authors.forename: A J
authors.initials: AJ
authors.lastname: Pollak
authors.forename: I
authors.initials: I
authors.lastname: Mena
authors.forename: S M
authors.initials: SM
authors.lastname: Shapiro
authors.forename: L E
authors.initials: LE
authors.lastname: Ginzton
authors.forename: K A
authors.initials: KA
authors.lastname: Narahara
mesh_terms: D005260:Female; D006801:Humans; D007089:Image Enhancement; D008297:Male; D008875:Middle Aged; D017682:Myocardial Stunning / Q000000981:diagnostic imaging*; D005996:Nitroglycerin; D012680:Sensitivity and Specificity; D013794:Thallium Radioisotopes; D015899:Tomography, Emission-Computed, Single-Photon; D014665:Vasodilator Agents
chemical_list: D013794:Thallium Radioisotopes; D014665:Vasodilator Agents; D005996:Nitroglycerin